Webcasts
Webinar Date/Time: Tue, Sep 24, 2024 1:00 PM EDT
Patients can’t afford to wait any longer for life-saving treatments. Trial operations need to be more predictable and streamlined, and therapies should work for everyone, everywhere. Learn how clinical trial innovators are solving big problems
Register Free:
https://www.biopharminternational.com/bp_w/speed-scale-access
Event Overview:
In the current drug development landscape, 85% of clinical trials experience delays, 11% of study costs are related to screen failures, and patient populations are often only 5% African American and 1% Latinx.
The time for change is now.
Patients can’t afford to wait any longer for life-saving treatments; trial operations need to be more predictable and streamlined; and therapies should work for everyone, everywhere.
To deliver true progress, the multiple challenges we face must be tackled together.
Join this webcast to hear clinical research innovators discuss how they’re increasing patient access and engagement, accelerating study startup and run speed, and improving the scalability of global clinical trials from different perspectives: technology, retail health, and biopharma. Register now!
Key Learning Objectives:
Who Should Attend:
Speakers:
Aadhar Shah, PharmD, MBA
VP, Growth & Strategy
Medable Inc
Aadhar Shah, Pharm D, MBA, holds the position of vice president of Growth & Strategy at Medable Inc. In this role, he is responsible for developing market strategies and creating value for enterprise customers on a large scale. Throughout his career, Shah has concentrated on the fields of life sciences, health care, digital technology, and data. By exploring the connections between these areas, he has sought to identify opportunities that can have a significant impact on improving patient health. Shah’s work also prioritizes achieving sustainable business outcomes. He has previous experience working in biopharma, strategy consulting, and with clients ranging from biopharma, providers, payers, large technology and platform companies, and digital health companies. He has a doctor of pharmacy from Rutgers University, and an MBA from the Kellogg School of Management at Northwestern University.
Pamela Tenaerts, MD, MBA
Chief Scientific Officer
Medable Inc.
Pamela Tenaerts, MD, MBA, is chief scientific officer at Medable Inc. Dr Tenaerts leads efforts to drive responsible adoption of decentralized research methodologies with evidence-based metrics and best practices. Dr Tenaerts joined Medable from Duke University, where she led the clinical trials transformation initiative’s (Public Private Partnership cofounded by Duke University and the Food and Drug Administration) efforts to develop and drive adoption of practices that increase the quality and efficiency of clinical trials. She is a member of the Drug Forum at the National Academies of Science, a member of the Digital Medicine Society founding members council, and a board member of the MedStar Research Institute. Dr Tenaerts is one of the leading advocates for innovation in clinical trials, with an emphasis on protocol design and QbD, patient engagement, responsible evidence generation, and clinical trial methodology improvements. With more than 30 years of experience in the conduct of clinical trials across a number of stakeholders, she practiced medicine in both the emergency department and as a family practitioner in the private practice setting before embarking on a career in research.
Mimi Fenton, PhD, MPhil, MPH
Head of Clinical Design & Strategic Growth
Walmart Healthcare Research Institute
Mimi Fenton, PhD, MPhil, MPH is an innovative clinical trial design executive, digital health pioneer, and strategy, operations, and business development leader. She is known in the industry for creating innovative clinical solutions and executing elegant studies with an understanding of the underlying science as well as the commercial opportunities and implications. Mimi joined Walmart in April 2023 and serves as Head of Clinical Design and Strategic Growth for the Walmart Healthcare Research Institute. In this remit, Mimi leads both the Strategic Growth (business development, strategic partnerships, proposals) and Research Science (medical affairs, real-world evidence, epidemiology, biostatistics, data analysis, data science) teams. Mimi has 20+ years of healthcare research leadership (Retail/Pharmacy, CRO/CCO, Pharma and Academia). Prior to joining Walmart, Mimi was the VP, Head of Strategic Clinical Development, and Head of Digital Health Strategy at Syneos Health. She has a PhD in Epidemiology from Columbia University, an MPH from Brown University, and a BA from the University of Pennsylvania in psychology. She has provided significant thought leadership with ~ 30 peer reviewed articles and serves as a reviewer for leading journals, including JAMA and BMJ. Mimi is a 2024 honoree of the Marquis Who’s Who in America and serves on the Board of Directors for the Arkansas Children's Hospital Research Institute and on the Board of Advisors for Carna Health and Uncommon Cures.
Register Free:
https://www.biopharminternational.com/bp_w/speed-scale-access